Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Oncology
  • Published:

Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle

British Journal of Cancer volume 63, pages 930–932 (1991)Cite this article

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. I.C.R.F., Medical Oncology Unit, Western General Hospital, Edinburgh, UK

    P Mullen

Authors
  1. P Mullen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. WN Scott
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. WR Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mullen, P., Scott, W. & Miller, W. Growth inhibition observed following administration of an LHRH agonist to a clonal variant of the MCF-7 breast cancer cell line is accompanied by an accumulation of cells in the G0/G1 phase of the cell cycle. Br J Cancer 63, 930–932 (1991). https://doi.org/10.1038/bjc.1991.203

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1991.203

This article is cited by

Search

Advanced search

Quick links